AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise

AngioDynamics, Inc. (ANGO) reported an adjusted loss per share of 11 cents for first-quarter fiscal 2025, against the year-ago quarter’s adjusted loss per share of 12 cents. The metric was also narrower than the Zacks Consensus Estimate of 15 cents.On a pro-forma basis (excluding Dialysis and BioSentry businesses, the divested PICC, Midline, and tip location product portfolios, and discontinued RadioFrequency and Syntrax support catheter products), adjusted loss per share in first-quarter fiscal 2025 was 11 ...